← Back to catalogue

Anti-Ca19-9

FDA UDI

Class I (US FDA UDI)

by Biogenex Laboratories, Inc.

Identity

Trade Name
ANTI-CA19-9 FDA UDI
Generic Name
Cancer antigen 19-9 (CA19-9) GI IVD, antibody FDA UDI
Model / Reference
AM424-5M FDA UDI

Identifiers

Catalog Number
AM424-5M FDA UDI
Primary DI / UDI-DI
00810119670694 FDA UDI
FDA Product Code
NJT FDA UDI
GMDN Term
Cancer antigen 19-9 (CA19-9) GI IVD, antibody FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 6 Milliliter FDA UDI

Category: Cancer antigen 19-9 (CA19-9) GI IVD, antibody

Anti-Ca19-9 by Biogenex Laboratories, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cancer antigen 19-9 (CA19-9) GI IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 195988b3-9d4e-493e-a96b-46b4b57473b1 35 fields · synced Jun 8, 2026